---
title: "STRL Jumps 4.10% as Value Stocks Gain Traction"
canonical_url: https://www.stockexpertai.com/journal/2026-02-11/strl-jumps-410-as-value-stocks-gain-traction
last_updated: 2026-02-11T18:06:27.954Z
section: "Weekly Picks"
author: "Alex Sterling"
publisher: Stock Expert AI
tickers: STRL, MSI, ARGX, HRMY, ERIC, ACM, NNBR, ESAB
content_type: journal-article
---

# STRL Jumps 4.10% as Value Stocks Gain Traction

## The Take
- Focus on value stocks like STRL and MSI, considering entry points around recent support levels and managing risk with stop-loss orders.

_This week's watchlist focuses on value opportunities in the market, considering entry points and potential risks._

Markets are signaling something important today. Value stocks are showing renewed strength, and several sectors are presenting interesting entry points for investors. This week, we'll examine a few stocks that have caught our attention, focusing on potential upside and key risk factors. While the SPY experienced a slight dip of -0.26%, specific stocks like STRL are bucking the trend. 

Sterling Infrastructure (STRL) is showing significant momentum, up 4.10% to $432.57. As investors weigh Aecom Technology (ACM) against STRL, it's clear that STRL is currently outperforming. Consider a pullback towards the $425 level as a potential entry point. However, be aware of potential profit-taking that could lead to increased volatility. A stop-loss order slightly below the $420 mark might be a prudent risk management strategy.

Motorola (MSI) is another stock on our radar, rising 0.32% to $421.03. In the Wireless Equipment sector, the debate between Ericsson (ERIC) and MSI continues. While ERIC dipped -0.89% to $11.13, MSI's relative strength is notable. Look for potential entry points around the $415-$420 range, but be mindful of broader market sentiment impacting the sector. Key risk: increased competition within the wireless space.

Lastly, we are watching argenex SE (ARGX) closely. While HRMY fell -2.98% to $36.80, ARGX experienced a smaller decline of -0.44% to $829.51. The biotech sector can be volatile, so a careful approach is warranted. A possible entry point could be considered if ARGX approaches the $820 level, with a tight stop-loss order placed to mitigate potential downside. The primary risk lies in clinical trial outcomes and regulatory approvals.

Keep these levels in mind as you navigate today's session.

## Related Tickers
- [STRL](https://www.stockexpertai.com/stock/strl)
- [MSI](https://www.stockexpertai.com/stock/msi)
- [ARGX](https://www.stockexpertai.com/stock/argx)
- [HRMY](https://www.stockexpertai.com/stock/hrmy)
- [ERIC](https://www.stockexpertai.com/stock/eric)
- [ACM](https://www.stockexpertai.com/stock/acm)
- [NNBR](https://www.stockexpertai.com/stock/nnbr)
- [ESAB](https://www.stockexpertai.com/stock/esab)

## Frequently Asked Questions

### What are value stocks?
Value stocks are shares of companies that appear to be trading for less than their intrinsic value. Investors often look for value stocks in sectors that are out of favor or experiencing temporary headwinds. These stocks are often characterized by low price-to-earnings ratios, high dividend yields, and strong fundamentals.

### How do I choose a value stock?
Choosing a value stock involves thorough research. Investors should analyze a company's financial statements, including its balance sheet, income statement, and cash flow statement. Key metrics to consider include price-to-earnings ratio, price-to-book ratio, and debt levels. Understanding the company's industry and competitive landscape is also crucial.

---
_AI-generated under human editorial supervision. Educational research, not financial advice._